2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide

C25H34F2N4O4S — CID 170791251

IUPAC2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide
SMILESCS(=O)(=O)Nc1ccc(C(=O)NC2CCN(C3CCC(F)(F)CC3)C2=O)c(N2CCC3(CC2)CC3)c1
InChIInChI=1S/C25H34F2N4O4S/c1-36(34,35)29-17-2-3-19(21(16-17)30-14-11-24(9-10-24)12-15-30)22(32)28-20-6-13-31(23(20)33)18-4-7-25(26,27)8-5-18/h2-3,16,18,20,29H,4-15H2,1H3,(H,28,32)
InChIKeyINHFBKDIVDCZGT-UHFFFAOYSA-N
MW524.63 g/mol
LogP3.35
Rot. Bonds6

About 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide

2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide (PubChem CID 170791251) has the molecular formula C25H34F2N4O4S and a molecular weight of 524.63 g/mol. Its IUPAC name is 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide.

Molecular Properties

Compound Name2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide
PubChem CID170791251
Molecular FormulaC25H34F2N4O4S
Molecular Weight524.63 g/mol
Exact Mass524.23
IUPAC Name2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide
SMILESCS(=O)(=O)Nc1ccc(C(=O)NC2CCN(C3CCC(F)(F)CC3)C2=O)c(N2CCC3(CC2)CC3)c1
InChIInChI=1S/C25H34F2N4O4S/c1-36(34,35)29-17-2-3-19(21(16-17)30-14-11-24(9-10-24)12-15-30)22(32)28-20-6-13-31(23(20)33)18-4-7-25(26,27)8-5-18/h2-3,16,18,20,29H,4-15H2,1H3,(H,28,32)
InChIKeyINHFBKDIVDCZGT-UHFFFAOYSA-N
XLogP3.35
TPSA98.82 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500524.63
LogP ≤ 53.35
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide?
The IUPAC name of 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide (CID 170791251) is 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide.
What is the SMILES notation for 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide?
The canonical SMILES for 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide is CS(=O)(=O)Nc1ccc(C(=O)NC2CCN(C3CCC(F)(F)CC3)C2=O)c(N2CCC3(CC2)CC3)c1.
What is the InChIKey of 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide?
The InChIKey is INHFBKDIVDCZGT-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H34F2N4O4S/c1-36(34,35)29-17-2-3-19(21(16-17)30-14-11-24(9-10-24)12-15-30)22(32)28-20-6-13-31(23(20)33)18-4-7-25(26,27)8-5-18/h2-3,16,18,20,29H,4-15H2,1H3,(H,28,32).
What are the key properties of 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide?
2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide has a molecular weight of 524.63 g/mol, XLogP of 3.35, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(6-azaspiro[2.5]octan-6-yl)-N-[1-(4,4-difluorocyclohexyl)-2-oxopyrrolidin-3-yl]-4-(methanesulfonamido)benzamide is sourced from PubChem (CID 170791251), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).